Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Incannex Healthcare Inc. - Common Stock
(NQ:
IXHL
)
4.000
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Mar 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Incannex Healthcare Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More
↗
September 18, 2023
Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next
Via
Benzinga
4 Of The 6 Largest Psychedelic Compound-Based R & D Stocks Had A Good Week
↗
September 17, 2023
4 of the 6 psychedelic-compound-based research & development stocks in our Psychedelic Drug Stocks Index were up in price last week versus only 1 the previous week. The Index was up 2.4% for the week...
Via
Talk Markets
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
↗
September 11, 2023
Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, An AI Predictive Model, And UK’s Struggle For Reclassification
Via
Benzinga
Topics
Artificial Intelligence
6 Largest Psychedelic Compound-Based R & D Stocks In Decline
↗
September 10, 2023
The 6 psychedelic compound-based research & development stocks in our Psychedelic Drug Stocks Index were down 2.6%, on average, this week and are now only up 6.5% YTD.
Via
Talk Markets
6 Largest Psychedelic Compound-Based R & D Stocks Up 4%, On Average, Last Week
↗
September 05, 2023
The 6 psychedelic compound-based research & development stocks in our munKNEE Psychedelic Drug Stocks Index were UP 3.9%, on average, last week and are now only UP 9.4% YTD.
Via
Talk Markets
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
↗
September 05, 2023
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety
Via
Benzinga
August Recap: Largest Psychedelic Compound-Based R & D Stocks Down 15%
↗
September 02, 2023
The 6 psychedelic compound-based research & development stocks in our Psychedelic Drug Stocks Index were down 15.0%, on average, in August and are now only up 5.3% YTD.
Via
Talk Markets
Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More
↗
August 28, 2023
Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials
Via
Benzinga
6 Largest Psychedelic Compound-Based R&D Stocks Continued Downwards, On Average, This Week
↗
August 25, 2023
Only 2 of the 6 psychedelic compound-based research & development stocks in our Psychedelic Drug Stocks Index were up this week.
Via
Talk Markets
Cannabis Stock Gainers And Losers From August 24, 2023
↗
August 24, 2023
Via
Benzinga
Topics
Cannabis
Incannex preparing psilocybin therapy FDA IND application
August 24, 2023
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) chief medical officer Dr Mark Bleakley tells Proactive the company is preparing an application to gain key regulatory approval to begin clinical trials in...
Via
TheNewswire.com
Incannex preparing psilocybin therapy FDA IND application
August 24, 2023
--News Direct--
Via
News Direct
Incannex To Prepare FDA IND Application For Psilocybin-Assisted Psychedelic Psychotherapy
↗
August 24, 2023
Psychennex Pty Ltd, a subsidiary of Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has commenced preparations of an investigational new drug (‘IND’) application to the U.S.
Via
Benzinga
Incannex full steam ahead towards sleep apnoea trial
August 23, 2023
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) chief medical officer Dr Mark Bleakley speaks with Proactive after the company received clearance from the US Food and Drug Administration (FDA) to begin...
Via
TheNewswire.com
Topics
Cannabis
Incannex full steam ahead towards sleep apnoea trial
August 23, 2023
--News Direct--
Via
News Direct
Topics
Cannabis
FDA Approves Clinical Trial Of Incannex's Dronabinol-Based Drug For Obstructive Sleep Apnea
↗
August 22, 2023
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has received approval from the US Food and Drug Administration to conduct the company’s investigational new drug (&ls
Via
Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
↗
August 21, 2023
Via
Benzinga
Topics
Cannabis
Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
↗
August 21, 2023
Cannabis, Psychedelics Use And Binge Drinking At All-Time High Among Adults, Teens Remain Stable, Fed Study Finds
Via
Benzinga
Topics
Cannabis
Economy
Largest Psychedelic Compound-Based R&D Stocks Continue Downward Trend
↗
August 20, 2023
The 6 psychedelic compound-based research & development stocks in our munKNEE Psychedelic Drug Stocks Index were down an average of 6% last week and are now down 17.2% MTD. We take a look at them in...
Via
Talk Markets
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
August 17, 2023
Via
Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
↗
August 14, 2023
First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published
Via
Benzinga
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
↗
August 17, 2023
Via
Benzinga
Topics
Cannabis
So Far, August Isn't Kind To 4 Of 6 Constituents In Our Psychedelic Drug Stocks Index
↗
August 13, 2023
The 6 psychedelic compound-based research & development stocks in our munKNEE Psychedelic Drug Stocks Index are down an average of 11.9% so far in August but are still up YTD.
Via
Talk Markets
Clarion Clinics Begins Accepting Registrations For Psychedelic Treatment Interest
↗
August 08, 2023
Clarion Clinics Group Pty Ltd, a subsidiary of Incannex Healthcare Ltd (NASDAQ: IXHL) (ASX:IHL) is now accepting direct registration of interest in treatment from potential clients via its website...
Via
Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
↗
August 16, 2023
Via
Benzinga
Topics
Cannabis
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
↗
August 07, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 14, 2023
↗
August 14, 2023
Via
Benzinga
Topics
Cannabis
Cannabis Stock Gainers And Losers From August 11, 2023
↗
August 11, 2023
Via
Benzinga
Topics
Cannabis
Cannabis Stock Movers For August 10, 2023
↗
August 10, 2023
Via
Benzinga
Topics
Cannabis
Cannabis Stock Gainers And Losers From August 4, 2023
↗
August 04, 2023
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.